Mechanism of action of 5-arninosalicylic acid
5-Aminosalicylic Acid (5-ASA) has been used for over 50 years in the treatment of inflammatory bowel disease in the pro-drug form sulphasalazine (SASP). SASP is also used to treat rheumatoid arthritis. However whether the therapeutic properties of SASP are due to the intact molecule, the 5-ASA or su...
Saved in:
Main Authors: | N. A. Punchard, S. M. Greenfield, R. P. H. Thompson |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1992-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/S0962935192000243 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and Mode of Action of Diabetes Medications in comparison with 5-Aminolevulinic Acid (5-ALA)
by: Peter R. Rehani, et al.
Published: (2019-01-01) -
Lipopolysaccharide and silica-stimulated mononuclear cell prostaglandin production in ulcerative colitis
by: Neville A. Punchard, et al.
Published: (2000-01-01) -
Caffeine's Vascular Mechanisms of Action
by: Darío Echeverri, et al.
Published: (2010-01-01) -
Corrigendum to “Caffeine’s Vascular Mechanisms of Action”
by: Darío Echeverri, et al.
Published: (2019-01-01) -
Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma
by: V. H. J. van der Velden
Published: (1998-01-01)